Subcutaneous Interferon Beta-1a 22/44 mg Demonstrates Comparable Effectiveness Versus Teriflunomide in Newly Treated Patients with Multiple Sclerosis. a Study in a French Nationwide Cohort of Multiple Sclerosis: Observatoire Francais De La Sclérose En Pla
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI